Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends

Moien Abdul Basith Khan, Muhammad Jawad Hashim, Jeffrey Kwan King, Romona Devi Govender, Halla Mustafa, Juma Al Kaabi, Moien Abdul Basith Khan, Muhammad Jawad Hashim, Jeffrey Kwan King, Romona Devi Govender, Halla Mustafa, Juma Al Kaabi

Abstract

The rising burden of type 2 diabetes is a major concern in healthcare worldwide. This research aimed to analyze the global epidemiology of type 2 diabetes. We analyzed the incidence, prevalence, and burden of suffering of diabetes mellitus based on epidemiological data from the Global Burden of Disease (GBD) current dataset from the Institute of Health Metrics, Seattle. Global and regional trends from 1990 to 2017 of type 2 diabetes for all ages were compiled. Forecast estimates were obtained using the SPSS Time Series Modeler. In 2017, approximately 462 million individuals were affected by type 2 diabetes corresponding to 6.28% of the world's population (4.4% of those aged 15-49 years, 15% of those aged 50-69, and 22% of those aged 70+), or a prevalence rate of 6059 cases per 100,000. Over 1 million deaths per year can be attributed to diabetes alone, making it the ninth leading cause of mortality. The burden of diabetes mellitus is rising globally, and at a much faster rate in developed regions, such as Western Europe. The gender distribution is equal, and the incidence peaks at around 55 years of age. Global prevalence of type 2 diabetes is projected to increase to 7079 individuals per 100,000 by 2030, reflecting a continued rise across all regions of the world. There are concerning trends of rising prevalence in lower-income countries. Urgent public health and clinical preventive measures are warranted.

Keywords: Diabetes mellitus type 2; disease pattern; epidemiology; prevalence.

Conflict of interest statement

The authors declare they have no conflicts of interest.

© 2019 Atlantis Press International B.V.

Figures

Figure 1
Figure 1
Global distribution of diabetes mellitus type 2 prevalence. Note: Colors indicate prevalence rates per 100,000 population in 2017.
Figure 2
Figure 2
Trends in the prevalence of type 2 diabetes. Note: Forecast estimates using SPSS Time Series Modeler (Ljung Box Q, p = 0.16). Dotted lines indicate upper and lower confidence limits.
Figure 3
Figure 3
Age distribution of diabetes mellitus type 2, worldwide. (A) Incidence vs. prevalence (both 2017). (B) Incidence in 1990 vs. 2017. p < 0.0001, chi-square test.

References

    1. Onyango EM, Onyango BM. The rise of noncommunicable diseases in Kenya: an examination of the time trends and contribution of the changes in diet and physical inactivity. J Epidemiol Glob Health. 2018;8:1–7. doi: 10.2991/j.jegh.2017.11.004.
    1. Ramtahal R, Khan C, Maharaj-Khan K, Nallamothu S, Hinds A, Dhanoo A, et al. Prevalence of self-reported sleep duration and sleep habits in type 2 diabetes patients in South Trinidad. J Epidemiol Glob Health. 2015;5:S35–S43. doi: 10.1016/j.jegh.2015.05.003.
    1. Alotaibi A, Perry L, Gholizadeh L, Al-Ganmi A. Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: an overview. J Epidemiol Glob Health. 2017;7:211–18. doi: 10.1016/j.jegh.2017.10.001.
    1. Lone S, Lone K, Khan S, Pampori RA. Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF. J Epidemiol Glob Health. 2017;7:235–9. doi: 10.1016/j.jegh.2017.07.004.
    1. Mahanta TG, Joshi R, Mahanta BN, Xavier D. Prevalence of modifiable cardiovascular risk factors among tea garden and general population in Dibrugarh, Assam, India. J Epidemiol Glob Health. 2013;3:147–56. doi: 10.1016/j.jegh.2013.04.001.
    1. Oluyombo R, Olamoyegun MA, Olaifa O, Iwuala SO, Babatunde OA. Cardiovascular risk factors in semi-urban communities in southwest Nigeria: patterns and prevalence. J Epidemiol Glob Health. 2015;5:167–74. doi: 10.1016/j.jegh.2014.07.002.
    1. Al-Maskari F, El-Sadig M, Nagelkerke N. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates. BMC Public Health. 2010;10:679. doi: 10.1186/1471-2458-10-679.
    1. Al Slail FY, Abid O, Assiri AM, Memish ZA, Ali MK. Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia. J Epidemiol Glob Health. 2016;6:29–36. doi: 10.1016/j.jegh.2015.07.004.
    1. Hashim MJ, Mustafa H, Ali H. Knowledge of diabetes among patients in the United Arab Emirates and trends since 2001: a study using the Michigan Diabetes Knowledge Test. East Mediterr Health J. 2017;22:742–8. doi: 10.26719/2016.22.10.742.
    1. Zimmet P. The global epidemiology of diabetes mellitus. Tohoku J Exp Med. 1983;141:41–54. doi: 10.1620/tjem.141.Suppl_41.
    1. Leach-Kemon K, Gall J. Why estimate? Seattle, Washington: Institute for Health Metrics and Evaluation; 2018. Available from: (accessed June 18, 2019).
    1. Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP) Diabetes Care. 2002;25:1551–6. doi: 10.2337/diacare.25.9.1551.
    1. Meo SA, Sheikh SA, Sattar K, Akram A, Hassan A, Meo AS, et al. Prevalence of type 2 diabetes mellitus among men in the Middle East: a retrospective study. Am J Mens Health. 2019;13:1557988319848577. doi: 10.1177/1557988319848577.
    1. Arab M. Diabetes mellitus in Egypt. World Health Stat Q. 1992;45:334–7.
    1. Musaiger AO. Diabetes mellitus in Bahrain: an overview. Diabet Med. 1992;9:574–8. doi: 10.1111/j.1464-5491.1992.tb01842.x.
    1. Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: where we stand and where we are headed. Ann Glob Health. 2015;81:839–50. doi: 10.1016/j.aogh.2015.10.003.
    1. Kadiki OA, Reddy MRS, Marzouk AA. Incidence of insulin-dependent diabetes (IDDM) and non-insulin-dependent diabetes (NIDDM) (0–34 years at onset) in Benghazi, Libya. Diabetes Res Clin Pract. 1996;32:165–73. doi: 10.1016/0168-8227(96)01262-4.
    1. Bo A, Thomsen RW, Nielsen JS, Nicolaisen SK, Beck-Nielsen H, Rungby J, et al. Early-onset type 2 diabetes: age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes—results from the DD2 study. Diabetes Metab Res Rev. 2018;34:e2968. doi: 10.1002/dmrr.2968.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다